Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 12/2022

14-07-2022 | Strabismus | Oculoplastics and Orbit

Ocular hypertension in patients with active thyroid-associated orbitopathy: a predictor of disease severity, particularly of extraocular muscle enlargement

Authors: Marta Karhanová, Jana Kalitová, Radim Kovář, Jan Schovánek, David Karásek, Jakub Čivrný, Petra Hübnerová, Petr Mlčák, Martin Šín

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 12/2022

Login to get access

Abstract

The purpose was to ascertain if any relation exists between the elevated intraocular pressure (IOP) in patients with thyroid-associated orbitopathy (TAO) in active stage and the severity of extraocular muscle involvement and the extent of exophthalmos.

Methods

A total of 96 eyes and orbits of 48 adult patients with active TAO were investigated. All patients underwent magnetic resonance imaging of the orbit and measurement of all extraocular recti muscles (EOM). The obtained data was divided into two groups according to the IOP value: normal IOP ≤ 21 mmHg; n = 47 and elevated IOP with IOP > 21 mmHg; n = 49, and analyszed.

Results

A significant difference was found in the short diameter of medial rectus and inferior rectus muscles and in the sum of short parameters of all EOM. All these parameters were significantly higher in the elevated IOP group. Motility restriction in at least one gaze direction was also significantly more frequent (p < 0.0001) in the elevated IOP group. A positive moderate correlation was found between IOP and the sum of short parameters of EOM (r = 0.496). No correlation was found between the IOP and exophthalmos values (r = 0.267). During the follow-up, the frequency of strabismus surgery and orbital decompression was significantly higher in the elevated IOP group (p = 0.003; p = 0.002).

Conclusion

Elevated IOP in the active TAO stage particularly correlates with extraocular muscle involvement. These patients are also more likely to require orbital decompression and strabismus surgery. https://static-content.springer.com/image/art%3A10.1007%2Fs00417-022-05760-0/MediaObjects/417_2022_5760_Figa_HTML.png
Literature
1.
go back to reference Wessely K (1918) Discussion of Hertel E. Der Dtsch Ophthlmol Ges 41:80–81 Wessely K (1918) Discussion of Hertel E. Der Dtsch Ophthlmol Ges 41:80–81
2.
go back to reference Ohtsuka K, Nakamura Y (2000) Open-angle glaucoma associated with Graves disease. Am J Ophthalmol 129(5):613–617CrossRefPubMed Ohtsuka K, Nakamura Y (2000) Open-angle glaucoma associated with Graves disease. Am J Ophthalmol 129(5):613–617CrossRefPubMed
3.
go back to reference Behrouzi Z, Rabei HM, Azizi F, Daftarian N, Mehrabi Y, Ardeshiri M, Mohammadpour M (2007) Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy. J Glaucoma 16(4):358–362CrossRefPubMed Behrouzi Z, Rabei HM, Azizi F, Daftarian N, Mehrabi Y, Ardeshiri M, Mohammadpour M (2007) Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy. J Glaucoma 16(4):358–362CrossRefPubMed
4.
go back to reference Cockerham KP, Pal C, Jani B, Wolter A, Kennerdell JS (1997) The prevalence and implications of ocular hypertension and glaucoma in thyroid-associated orbitopathy. Ophthalmology 104(6):914–917CrossRefPubMed Cockerham KP, Pal C, Jani B, Wolter A, Kennerdell JS (1997) The prevalence and implications of ocular hypertension and glaucoma in thyroid-associated orbitopathy. Ophthalmology 104(6):914–917CrossRefPubMed
5.
go back to reference Kalmann R, Mourits MP (1998) Prevalence and management of elevated intraocular pressure in patients with Graves’ orbitopathy. Br J Ophthalmol 82:754–757CrossRefPubMedPubMedCentral Kalmann R, Mourits MP (1998) Prevalence and management of elevated intraocular pressure in patients with Graves’ orbitopathy. Br J Ophthalmol 82:754–757CrossRefPubMedPubMedCentral
6.
go back to reference Da Silva FLM, de Lourdes Veronese Rodrigues M, Akaishi PMS, Cruz AAV (2009) Graves’ orbitopathy: frequency of ocular hypertension and glaucoma. Eye 23(4):957–959CrossRefPubMed Da Silva FLM, de Lourdes Veronese Rodrigues M, Akaishi PMS, Cruz AAV (2009) Graves’ orbitopathy: frequency of ocular hypertension and glaucoma. Eye 23(4):957–959CrossRefPubMed
7.
go back to reference Konuk O, Onaran Z, Ozhan Oktar S, Yucel C, Unal M (2009) Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves’ orbitopathy: relation with the clinical features. Graefes Arch Clin Exp Ophthalmol 247(11):1555–1559CrossRefPubMed Konuk O, Onaran Z, Ozhan Oktar S, Yucel C, Unal M (2009) Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves’ orbitopathy: relation with the clinical features. Graefes Arch Clin Exp Ophthalmol 247(11):1555–1559CrossRefPubMed
8.
go back to reference Mouritz MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R (1989) Clinical criteria for the assessment of disease activity in Graves´ ophthalmopathy: a novel approach. Br J Ophthalmol 73:639–644CrossRef Mouritz MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R (1989) Clinical criteria for the assessment of disease activity in Graves´ ophthalmopathy: a novel approach. Br J Ophthalmol 73:639–644CrossRef
9.
go back to reference Åsman P (2003) Ophthalmological evaluation in thyroid-associated ophthalmopathy. Acta Ophthalmol Scand 81:437–448CrossRefPubMed Åsman P (2003) Ophthalmological evaluation in thyroid-associated ophthalmopathy. Acta Ophthalmol Scand 81:437–448CrossRefPubMed
10.
go back to reference Werner SC (1977) Modification of the classification of the eye changes of Graves´ disease: recommendations of the Ad Hoc Commitee of the American Thyroid Association. J Clin Endocrinol Metab 44:203–204CrossRefPubMed Werner SC (1977) Modification of the classification of the eye changes of Graves´ disease: recommendations of the Ad Hoc Commitee of the American Thyroid Association. J Clin Endocrinol Metab 44:203–204CrossRefPubMed
11.
go back to reference Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, European Group on Graves’ orbitopathy (EUGOGO) (2016) The 2016 European Thyroid Association/European Group on Graves’ Orbitopathy Guidelines for the management of Graves’ orbitopathy. Eur Thyroid J 5(1):9–26CrossRefPubMedPubMedCentral Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, European Group on Graves’ orbitopathy (EUGOGO) (2016) The 2016 European Thyroid Association/European Group on Graves’ Orbitopathy Guidelines for the management of Graves’ orbitopathy. Eur Thyroid J 5(1):9–26CrossRefPubMedPubMedCentral
12.
go back to reference Wiersinga WM, Kahaly GJ (eds) (2010) Graves’ orbitopathy: a multidisciplinary approach-questions and answers, 2nd revised. Karger, Basel, pp 33–39 Wiersinga WM, Kahaly GJ (eds) (2010) Graves’ orbitopathy: a multidisciplinary approach-questions and answers, 2nd revised. Karger, Basel, pp 33–39
14.
go back to reference Nassr MA, Morris CL, Netland PA, Karcioglu ZA (2009) Intraocular pressure change in orbital disease. Surv Ophthalmol 54(5):519–544CrossRefPubMed Nassr MA, Morris CL, Netland PA, Karcioglu ZA (2009) Intraocular pressure change in orbital disease. Surv Ophthalmol 54(5):519–544CrossRefPubMed
15.
go back to reference Gumińska M, Goś R, Śmigielski J, Nowak MS (2020) Topical treatment of elevated intraocular pressure in patients with Grave’s orbitopathy. Int J Environ Res Public Health 17:9331CrossRefPubMedCentral Gumińska M, Goś R, Śmigielski J, Nowak MS (2020) Topical treatment of elevated intraocular pressure in patients with Grave’s orbitopathy. Int J Environ Res Public Health 17:9331CrossRefPubMedCentral
16.
go back to reference Gharib S, Moazezi Z, Bayani MA (2018) Prevalence and severity of ocular involvement in Graves’ disease according to sex and age: a clinical study from Babol, Iran. Caspian J Intern Med 9(2):178–183PubMedPubMedCentral Gharib S, Moazezi Z, Bayani MA (2018) Prevalence and severity of ocular involvement in Graves’ disease according to sex and age: a clinical study from Babol, Iran. Caspian J Intern Med 9(2):178–183PubMedPubMedCentral
17.
go back to reference Kuebler AG, Wiecha C, Reznicek L, Klingenstein A, Halfter K, Priglinger S, Hintschich, (2019) Comparison of different devices to measure the intraocular pressure in thyroid-associated orbitopathy. Graefes Arch Clin Exp Ophthalmol 257:2025–2032CrossRefPubMed Kuebler AG, Wiecha C, Reznicek L, Klingenstein A, Halfter K, Priglinger S, Hintschich, (2019) Comparison of different devices to measure the intraocular pressure in thyroid-associated orbitopathy. Graefes Arch Clin Exp Ophthalmol 257:2025–2032CrossRefPubMed
18.
go back to reference Stoyanova NS, Konareva-Kostianeva M, Mitkova-Hristova V, Anglova I (2019) Correlation between intraocular pressure and thickness of extraocular muscles, the severity and activity of thyroid-associated orbitopathy. Folia Med (Plovdiv) 61(1):90–96CrossRef Stoyanova NS, Konareva-Kostianeva M, Mitkova-Hristova V, Anglova I (2019) Correlation between intraocular pressure and thickness of extraocular muscles, the severity and activity of thyroid-associated orbitopathy. Folia Med (Plovdiv) 61(1):90–96CrossRef
19.
go back to reference Wilinsky RA, Arenson AM, Hurwitz JJ, Szalai J (1984) Ultrasonic B-scan measurement of the extraocular muscles in Graves’ orbitopathy. J Can Assoc Radiol 35:171–173 Wilinsky RA, Arenson AM, Hurwitz JJ, Szalai J (1984) Ultrasonic B-scan measurement of the extraocular muscles in Graves’ orbitopathy. J Can Assoc Radiol 35:171–173
20.
go back to reference Fledelius C, Zimmermann-Bielsing T, Feldt-Rasmussen U (2003) Ultrasonically measured horizontal eye muscle thickness in thyroid associated orbitopathy: cross-sectional and longitudinal aspects in a Danish series. Acta Oftalmol Scand 81:143–150CrossRef Fledelius C, Zimmermann-Bielsing T, Feldt-Rasmussen U (2003) Ultrasonically measured horizontal eye muscle thickness in thyroid associated orbitopathy: cross-sectional and longitudinal aspects in a Danish series. Acta Oftalmol Scand 81:143–150CrossRef
21.
go back to reference Imbrasienė D, Jankauskienė J, Stanislovaitienė D (2010) Ultrasonic measurement of ocular rectus muscle thickness in patients with Graves’ ophthalmopathy. Medicina (Kaunas) 46:472–476CrossRef Imbrasienė D, Jankauskienė J, Stanislovaitienė D (2010) Ultrasonic measurement of ocular rectus muscle thickness in patients with Graves’ ophthalmopathy. Medicina (Kaunas) 46:472–476CrossRef
22.
go back to reference Karhanova M, Kovar R, Frysak Z, Sin M, Zapletalova J, Rehak J, Herman M (2015) Correlation between magnetic resonance imaging and ultrasound measurements of eye muscle thickness in thyroid-associated orbitopathy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 159(2):307–312CrossRefPubMed Karhanova M, Kovar R, Frysak Z, Sin M, Zapletalova J, Rehak J, Herman M (2015) Correlation between magnetic resonance imaging and ultrasound measurements of eye muscle thickness in thyroid-associated orbitopathy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 159(2):307–312CrossRefPubMed
23.
go back to reference Spierer A, Eisenstein Z (1991) The role of increased intraocular pressure on upgaze in the assessment of Graves Ophthalmopathy. Ophthalmology 98:1491–1494CrossRefPubMed Spierer A, Eisenstein Z (1991) The role of increased intraocular pressure on upgaze in the assessment of Graves Ophthalmopathy. Ophthalmology 98:1491–1494CrossRefPubMed
24.
go back to reference Lennerstrand G, Tiam S, Isberg B, Landau Högbeck I, Bolzani R, Tallstedt L, Schworm (2007) Magnetic resonance imaging and ultrasound measurements of extraocular muscles in thyroid-associated ophthalmopathy at different stages of the disease. Acta Ophthalmol Scand 85:192–201CrossRefPubMed Lennerstrand G, Tiam S, Isberg B, Landau Högbeck I, Bolzani R, Tallstedt L, Schworm (2007) Magnetic resonance imaging and ultrasound measurements of extraocular muscles in thyroid-associated ophthalmopathy at different stages of the disease. Acta Ophthalmol Scand 85:192–201CrossRefPubMed
Metadata
Title
Ocular hypertension in patients with active thyroid-associated orbitopathy: a predictor of disease severity, particularly of extraocular muscle enlargement
Authors
Marta Karhanová
Jana Kalitová
Radim Kovář
Jan Schovánek
David Karásek
Jakub Čivrný
Petra Hübnerová
Petr Mlčák
Martin Šín
Publication date
14-07-2022
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 12/2022
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-022-05760-0

Other articles of this Issue 12/2022

Graefe's Archive for Clinical and Experimental Ophthalmology 12/2022 Go to the issue